Article
01 Sep 2023
Attorney Says PCCPs With Change In Indication For Use Not Completely Impracticable
AUTHORS CONTENT
Article
03 Aug 2023
5 Questions About Generative AI In Healthcare
Article
28 Jul 2023
FDA's Decentralized Trial Guidance: Investigator, Health Care Provider Demarcation Raises Questions
Article
05 Jul 2023
The EU's New Proposal For Plants Developed Using New Genomic Techniques: How Does It Compare To U.S. Regulation?
Article
19 Jun 2023
Will FDA's Accelerated Approval Pathway Facilitate Access To Gene Therapies As Applications Roll In?
Article
23 May 2023
FDA On Use Of AI/ML In Drug Development: Five Key Takeaways
Article
17 May 2023
FTC Issues Notice Of Penalty Offenses On Substantiation Of Product Claims
Article
10 May 2023
FDA Publishes Draft Guidance For Predetermined Change Control Plan For AI/ML-Enabled Device Software Functions
Article
12 Apr 2023
FDA Issues Final Transition Guidances For COVID-19 Devices
Article
05 Apr 2023
FDA Releases Draft Guidance For Labeling Of Plant-Based Milk Alternatives
Article
31 Mar 2023
FDA Publishes Digital Health Technology Framework
Article
01 Feb 2023
FTC Issues Updated Health Products Claims Guidance
Article
26 Jan 2023
FDA Updates COVID-19 Testing Guidances
Article
17 Jan 2023
Congress Expands FDA Authority Over Cosmetics
Article
16 Jan 2023
FDA Clarifies The Human Factors Or Usability Information To Include In A Device Marketing Submission
Article
24 Nov 2022
FDA Clears The Path To Lab-Grown Meat
Article
18 Nov 2022
FDA Clarifies ANDA Active Ingredient Sameness Evaluation In Draft Guidance
Article
30 Sep 2022
FDA Releases Foundational Digital Health Guidance
Article
26 Sep 2022
New Opportunities For Test Developers: Monkeypox Diagnostics
Article
08 Apr 2022
FDA Issues Draft Guidance On Human Gene Therapy Products Incorporating Human Genome Editing
